CBM
Cambrex Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.
Market Cap: 2.02 Billion
Primary Exchange: New York Stock Exchange
Website: http://www.cambrex.com
Shares Outstanding: 33.7 Million
Float: 33.4 Million
Dividend: (%)
Beta: 0.8277683726400173
Sector: Process Industries
Industry: Chemicals: Specialty
Ethical Flags
Longest drawdown: 679 trading days
From: 2018-09-28 To: 2019-12-03
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|